MarketCap
Facebook
X
Telegram
La Jolla Pharmaceutical Company EV/EBITDA Ratio | LJPC
Annual EV/EBITDA Ratio La Jolla Pharmaceutical Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.3 | -9.1 | -2.72 | -0.787 | -5.84 | -3.59 | -3.74 | -8.75 | -0.305 | -94.6 | -6.87 | 1.75 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.3 | -94.6 | -10.3 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aridis Pharmaceuticals
ARDS
|
-1.29 | - | 17.91 % | $ 11.1 M |  USA |
 |
Seagen
SGEN
|
-45.9 | - | - | $ 42.2 B | USA |
 |
Protara Therapeutics
TARA
|
-3.24 | $ 2.44 | -2.59 % | $ 105 M | USA |
 |
Baudax Bio
BXRX
|
-1.67 | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
-0.721 | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
-87.3 | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
-1.92 | - | 7.23 % | $ 2.72 M | USA |
 |
Oncternal Therapeutics
ONCT
|
-0.654 | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
-2.81 | - | - | $ 591 K |  Irlanda |
 |
Spectrum Pharmaceuticals
SPPI
|
-2.18 | - | - | $ 189 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.268 | - | - | $ 26.5 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-0.183 | - | - | $ 2.17 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
-0.207 | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
-4.27 | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
0.477 | - | -8.77 % | $ 12.4 M |  Israel |
 |
Histogen
HSTO
|
0.305 | - | 31.6 % | $ 2.12 M | USA |
 |
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | USA |
 |
Cidara Therapeutics
CDTX
|
-0.0568 | - | - | $ 1.41 B | USA |
 |
Clovis Oncology
CLVS
|
-19.7 | - | -7.23 % | $ 13 M | USA |
 |
Kaleido Biosciences
KLDO
|
-0.876 | - | -3.69 % | $ 12.4 M | USA |
 |
VBI Vaccines
VBIV
|
0.18 | - | -50.87 % | $ 1.09 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
-8.52 | - | - | $ 1.2 B | USA |
 |
Decibel Therapeutics
DBTX
|
-1.75 | - | - | $ 123 M | USA |
 |
NuCana plc
NCNA
|
-4.24 K | $ 0.94 | -2.67 % | $ 10.6 B |  Britain |
 |
PhaseBio Pharmaceuticals
PHAS
|
-2.14 | - | 7.4 % | $ 6.29 M | USA |
 |
Provention Bio
PRVB
|
-14.6 | - | - | $ 2.37 B | USA |
 |
IVERIC bio
ISEE
|
-13.8 | - | - | $ 5.51 B | USA |
 |
Reata Pharmaceuticals
RETA
|
1.42 K | - | - | $ 6.29 B | USA |
 |
ObsEva SA
OBSV
|
-1.92 | - | -15.52 % | $ 10.5 M |  Schweiz |
 |
PolarityTE
PTE
|
0.0431 | - | -0.82 % | $ 1.78 M | USA |
 |
Kronos Bio
KRON
|
0.524 | - | 1.49 % | $ 50.8 M | USA |
 |
Landos Biopharma
LABP
|
-0.743 | - | 0.58 % | $ 144 M | USA |
 |
Myovant Sciences Ltd.
MYOV
|
-3.16 | - | -0.04 % | $ 2.62 B | USA |
 |
Poseida Therapeutics
PSTX
|
-3.48 | - | - | $ 857 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.186 | - | - | $ 231 M | USA |
 |
Trevena
TRVN
|
-0.583 | - | -46.58 % | $ 31.8 M | USA |
 |
Immunovant
IMVT
|
13.9 K | $ 35.73 | 1.65 % | $ 6.52 B | USA |
 |
Virpax Pharmaceuticals
VRPX
|
-0.15 | - | -45.12 % | $ 2.85 M | USA |
 |
Oncorus
ONCR
|
-0.814 | - | -8.54 % | $ 3.19 M | USA |
 |
Y-mAbs Therapeutics
YMAB
|
-5.77 | - | - | $ 382 M | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
-1.39 | - | -2.99 % | $ 2.47 M | USA |
 |
InMed Pharmaceuticals
INM
|
25.4 | $ 15.56 | 13.57 % | $ 64.8 M |  Canada |
 |
Stealth BioTherapeutics Corp
MITO
|
-10.8 | - | - | $ 23.9 M | USA |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Satsuma Pharmaceuticals
STSA
|
-0.268 | - | -0.9 % | $ 36.5 M | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
-3.84 | $ 1.14 | -6.97 % | $ 97.2 M | USA |
 |
SpringWorks Therapeutics
SWTX
|
-16.3 | - | - | $ 3.48 B | USA |
 |
Metacrine
MTCR
|
0.582 | - | - | $ 24.2 M | USA |
 |
Turning Point Therapeutics
TPTX
|
-8.12 | - | -0.13 % | $ 3.73 B | USA |
 |
Infinity Pharmaceuticals
INFI
|
-0.898 | - | -46.98 % | $ 3.57 M | USA |